Author

F. Lasala

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 3 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Research Focus:host-pathogen & immune response· 3 Research Focus:cell-cell communication· 2 Research Focus:drug response / drug discovery· 2 Organism:human· 2 Research Focus:protein folding & dynamics· 1 Assay:proteomics· 1 Assay:spatial transcriptomics· 1

Frequent Co-Authors

R. Delgado· 4 shared J. Luczkowiak· 3 shared N. Labiod· 2 shared A. Bernardi· 1 shared A. Del Puerto· 1 shared C. Alonso· 1 shared C. H. Herbreteau· 1 shared C. Vives· 1 shared

Activity by Year

2019-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersMicrobiology

R. Delgado

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Potent Neutralizing Activity of Polyclonal Equine Antibodies against Omicron SARS-CoV-2

J. Luczkowiak, P. Radreau, L. Nguyen, N. Labiod, F. Lasala, C. H. Herbreteau, R. Delgado

This study demonstrates that equine polyclonal F(ab)2 antibodies achieve high neutralizing potency against SARS-CoV-2 variants, including Omicron, with titers up to 111,403 IU/mL.

bioRxiv · Feb 21, 2022 · PreprintMicrobiology

Endosomal proteins NPC1 and NPC2 at African swine fever virus entry/fusion

C. Alonso, M. A. Cuesta-Geijo, J. Urquiza, A. Del Puerto, I. Garcia-Dorival, F. Lasala, L. Barrado-Gil, I. Galindo, R. Delgado

This study identifies NPC1 and NPC2 as critical for ASFV membrane fusion, showing their role in viral entry and replication through interactions with viral proteins.

bioRxiv · Jul 7, 2021 · PreprintMicrobiology

DC/L-SIGN recognition of spike glycoprotein promotes SARS-CoV-2 trans-infection and can be inhibited by a glycomimetic antagonist

M. Thepaut, J. Luczkowiak, C. Vives, N. Labiod, I. Bally, F. Lasala, Y. Grimoire, D. Fenel, S. Sattin, N. Thielens, G. Schoehn, A. Bernardi, R. Delgado, F. Fieschi

The paper shows DC/L-SIGN receptors on antigen-presenting cells enhance SARS-CoV-2 trans-infection, which can be blocked by a glycomimetic compound.

bioRxiv · Aug 9, 2020Immunology

Glycosylation-dependent enhanced cell-binding and infectivity through DC-SIGN in the West African Ebola virus Makona

F. Lasala, J. Luczkowiak, L. Kremer, J. M. Casasnovas, R. Delgado

This study identifies a glycosylation-dependent enhancement in the binding and infectivity of the EBOV Makona variant through DC-SIGN, contributing to its rapid spread during the 2013-2016 West African epidemic.

bioRxiv · May 7, 2019 · PreprintMicrobiology